Neuroblastoma Screening at One Year of Age
Top Cited Papers
- 4 April 2002
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (14), 1047-1053
- https://doi.org/10.1056/nejmoa012277
Abstract
Neuroblastoma is the second most common type of childhood tumor. It is not known whether screening for neuroblastoma at one year of age reduces the incidence of metastatic disease or mortality due to neuroblastoma.This publication has 32 references indexed in Scilit:
- Survival of children with neuroblastoma: time trends and regional differences in Europe, 1978–1992European Journal of Cancer, 2001
- NeuroblastomaDrugs, 2000
- Randomized controlled trials in population-based intervention studies are not always feasibleMedical and Pediatric Oncology, 1999
- Neuroblastoma in Europe: differences in the pattern of disease in the UKThe Lancet, 1998
- A population-based study of the usefulness of screening for neuroblastomaThe Lancet, 1996
- Neuroblastoma mass screening: The arguments for and againstEuropean Journal of Cancer, 1995
- Is neuroblastoma screening evaluation needed and feasible?British Journal of Cancer, 1995
- Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.Journal of Clinical Oncology, 1995
- Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stageCancer, 1992
- Determination of urinary homovanillic and vanillylmandelic acids from dried filter paper samples: Assessment of potential methods for neuroblastoma screeningClinical Biochemistry, 1987